Therapeutic implications of immune‐profiling and <scp>EGFR</scp> expression in salivary gland carcinoma

Abstract

The data from this retrospective study highlighting the uniform microsatellite stability alongside the low prevalence of CPS positivity suggests that only a minority of SGC patients may benefit from ICI therapy alone. The high rates of EGFR expression in SGC may be a target to augment immune checkpoint therapy response.